文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

机器学习预测宫颈癌近距离治疗剂量参数的多中心分析

Multi-center analysis of machine-learning predicted dose parameters in brachytherapy for cervical cancer.
PubMed 文献 · Radiother Oncol · 2022-02-24

本研究纳入UMC Utrecht与Erasmus MC按现行图像引导自适应近距离治疗(IGABT)方案治疗的145例患者共223个计划,训练机器学习模型基于重叠体积直方图(OVH)预测膀胱、直肠、乙状结肠和小肠的D2cm3。结果显示同一方案内模型预测与计划D2cm3的均方误差为0.13–0.40 Gy,表明模型可跨中心迁移;而Erasmus MC旧方案队列的均方误差为0.84–4.71 Gy,提示计划偏离方案。

要点

  • 基于OVH的机器学习模型可预测膀胱、直肠、乙状结肠和小肠的D2cm3。
  • 同一方案内预测与计划D2cm3的均方误差为0.13–0.40 Gy,模型可跨中心迁移。
  • Erasmus MC旧方案队列均方误差为0.84–4.71 Gy,提示计划偏离方案。

核心结论

  • 基于OVH的模型在足够严格方案训练下可为多中心质量保证提供坚实基础。
  • 进一步研究将量化该模型作为质量保证工具的影响。

研究设计与样本

  • 多中心分析,纳入UMC Utrecht和Erasmus MC按现行IGABT方案治疗的145例患者共223个计划。
  • 训练机器学习模型基于OVH预测膀胱、直肠、乙状结肠和小肠的D2cm3。
  • 评估单中心模型对针使用和施源器类型的稳健性及多中心模型的可迁移性。

主要发现

  • UMC Utrecht数据内部验证显示OVH模型对针使用和施源器类型稳健。
  • UMC Utrecht数据训练的模型在Erasmus MC同一方案数据上对所有研究OAR稳健。
  • 同一方案内计划与预测D2cm3的均方误差为0.13–0.40 Gy,表明模型可迁移。
  • Erasmus MC旧方案队列计划与预测D2cm3偏差大,均方误差为0.84–4.71 Gy,提示计划偏离方案。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 进一步研究将量化该模型作为质量保证工具的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Image-guided adaptive brachytherapy (IGABT) is a key component in the treatment of cervical cancer, but the nature of the clinical workflow makes it vulnerable to suboptimal plans, as the theoretical optimal plan depends heavily on organ configuration. Patient anatomy-based quality-assurance (QA) with overlap volume histograms (OVHs) is a promising tool to detect such suboptimal plans, and in this analysis its suitability as a multi-institutional clinical QA tool is investigated. MATERIALS AND METHODS: A total of 223 plans of 145 patients treated in accordance with the current state-of-the-art IGABT protocols from UMC Utrecht (UMCU) and Erasmus MC (EMC) were included. Machine-learning models were trained to predict dose D2cm3 to bladder, rectum, sigmoid and small bowel with the help of OVHs. For this strategy, points are sampled on the organs-at-risk (OARs), and the distances of the sampled points to the target are computed and combined in a histogram. Machine-learning models can then be trained to predict dose-volume histograms (DVHs) for unseen data. Single-center model robustness to needle use and applicator type and multi-center model translatability were investigated. Performance of models was assessed by the difference between planned (clinical) and predicted D2cm3 values. RESULTS: Intra-validation of UMCU data demonstrated OVH model robustness to needle use and applicator type. The model trained on UMCU data was found to be robust within the same protocol on EMC data, for all investigated OARs. Mean squared error between planned and predicted D2cm3 values of OARs ranged between 0.13 and 0.40 Gy within the same protocol, indicating model translatability. For the former protocol cohort of Erasmus MC large deviations were found between the planned and predicted D2cm3 values, indicating plan deviation from protocol. Mean squared error for this cohort ranged from 0.84 to 4.71 Gy. CONCLUSION: OVH-based models can provide a solid basis for multi-institutional QA when trained on a sufficiently strict protocol. Further research will quantify the model's impact as a QA tool.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Reijtenbagh D, Godart J, de Leeuw A, et al. Multi-center analysis of machine-learning predicted dose parameters in brachytherapy for cervical cancer. Radiother Oncol. 2022. PMID: 35219799. doi:10.1016/j.radonc.2022.02.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。